Evidence map›Paper›PMID 37565045›Full record

ArticleQatar medical journal2023

Characteristics and outcomes of adult patients with asthma presenting with COVID-19: A comparative cohort study.

Eman Alhmoud, Raja Barazi, Mohammed Saad, Dania Al Khiyami, Reem El Ajez, Dana Bakdach, Ali Omrani, Wanis Ibrahim, Rasha El Anany, Moza Al-Hail

Abstract read
In one paragraph

Article in Qatar medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eman AlhmoudPharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ealhamoud@hamad.qa ORCID: 0000-0002-3871-7088.
Raja BaraziPharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ealhamoud@hamad.qa ORCID: 0000-0002-3871-7088.
Mohammed SaadPharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ealhamoud@hamad.qa ORCID: 0000-0002-3871-7088.
Dania Al KhiyamiPharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ealhamoud@hamad.qa ORCID: 0000-0002-3871-7088.
Reem El AjezPharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ealhamoud@hamad.qa ORCID: 0000-0002-3871-7088.
Dana BakdachPharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ealhamoud@hamad.qa ORCID: 0000-0002-3871-7088.
Ali OmraniDepartment of Medicine, Hamad Medical Corporation, Doha, Qatar.
Wanis IbrahimDepartment of Medicine, Hamad Medical Corporation, Doha, Qatar.
Rasha El AnanyPharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ealhamoud@hamad.qa ORCID: 0000-0002-3871-7088.
Moza Al-HailPharmacy Department, Hamad Medical Corporation, Doha, Qatar. E-mail: ealhamoud@hamad.qa ORCID: 0000-0002-3871-7088.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBronchial asthma affects about 20% of Qatar's population. The impact of asthma on COVID-19 outcomes is controversial. The aim of this study was to explore the impact of asthma on COVID-19 outcomes and the predictors of COVID-19-related morbidity and mortality in a cohort of asthma patients infected by COVID-19.

methodsThis is a retrospective cohort study of adult patients with asthma infected with COVID-19, who were recruited from Hamad Medical Corporation (HMC), the main healthcare system in Qatar. Patients were matched to a control group of non-asthmatic COVID-19 patients (1:2) based on sex, age, and other comorbidities.

resultsBetween March and August 2020, 616 patients with asthma met the inclusion criteria. The need for hospitalization among patients with asthma was independently associated with older age (adjusted odds ratio [aOR] for 10 years, 1.32; 95% confidence interval [CI], 1.13-1.54;

conclusionsIn Qatar, adult patients with asthma do not appear to be at higher risk of COVID-19-related hospitalization or ICU admission compared to the general adult COVID-19-infected population. Older age and hypertension were the only significant predictors of COVID-19-related hospitalization among patients with asthma. Further larger studies are required to confirm such an association.

Indexed as

AsthmaCOVID-19morbiditymortality

Identifiers

PMID37565045
PMCPMC10411356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.